India's biotechnology sector reaches a milestone of $165 billion in 2025 due to a burgeoning startup ecosystem and supportive ...

A man rides his motorbike past a parked bus of India's biotechnology company Bharat Biotech outside its office in Hyderabad BENGALURU (Reuters) -A top executive at an Indian biotechnology company ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...

Climate-resilient agriculture uses biotechnology, biofertilizers, biopesticides, genome-edited crops, and AI-driven tools to ...

BENGALURU (Reuters) - Bharat Biotech's vaccine showed 81% efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, it said on Wednesday, a major boost for the ...

RESEARCH TRIANGLE PARK, N.C., Oct. 17, 2011 /PRNewswire/ -- Max Neeman International is the only CRO in India to manage hemophilia trials according to the Clinical Trials Registry-India (CTRI). Of the ...

Most Preferred Workplaces 2025–26 Healthcare celebrated people-first, purpose-led organisations shaping India’s pharma and healthcare future.

It turns out a COVID-19 vaccine that stirred controversy in India may be effective after all. The Indian government approved the use of the COVAXIN vaccine, made by the Indian company Bharat Biotech, ...

Ananya Joshi revealed that she saw a LinkedIn posting for a biotech job in Germany just two hours before she was officially ...

Goodwin Biotechnology (www.goodwinbio.com) claims to be one of the oldest contract manufacturing organizations (CMO) of mAbs and recombinant proteins in the U.S. In 2004, Wallace Pharmaceuticals ...

India’s homegrown Covid-19 vaccine Covaxin has an efficacy rate of more than 93.4% against severe Covid-19 infection and 77.8% against symptomatic infection, according to data released Saturday by the ...

BENGALURU (Reuters) -A top executive at an Indian biotechnology company defended its COVID-19 vaccine candidate, approved for emergency use by the government, and said it will produce efficacy data ...